- Home
- Companies
- Quest Medical Inc.
- Products
- Quest - Model MPS 2 - Myocardial ...
Quest - Model MPS 2 - Myocardial Protection System
Technology so unique, Quest Medical was awarded eight U.S. patents for this perfusion system. At the heart of the MPS®2 system are Spline-Piston pumps coupled with state-of-the-art pressure sensors enabling unparalleled drug delivery accuracy. The Quest MPS 2 System provides independent control of potassium and carioprotective drugs, providing the flexibility to deliver any cardioplegia protocol or strategy.
The Quest Myocardial Protection System, consisting of the MPS 2 System Console and the MPS 2 System Delivery Set used together, is intended for use by perfusionists and physicians to deliver whole blood (from any arterial source) and/or cardioplegia solutions to the heart during open heart surgery up to six hours.
Deliver any cardioplegia strategy:
- Intermittent MicroplegiaTM
- Ratio cardioplegia (4:1, 8:1, 1:4)
- Extended arrest protocols (single-dose strategy)
Quest Microplegia with the Myocardial Protection System (MPS®) is a cost-effective strategy utilizing undiluted blood with targeted amounts of cardio protective additives, adjustable to meet the changing requirements of each patient. Adequacy of perfusion, early recovery of metabolism and function are best achieved with the MPS 2 system.
Other benefits:
- Dual delivery lines provide superior control of potassium and cardioprotective drugs
- No need to stop and manage clamps or valves
- The Auto-Pressure feature regulates and maintains targeted delivery pressure